The drug delivery systems market was valued around US$ 40 billion in 2022; from that year to 2032, it is anticipated to increase at a CAGR of more than 7.8%, reaching about US$ 80 billion. From 2022 to 2032, the demand for self-administration and home health care equipment is anticipated to fuel market expansion for drug delivery systems.
Big and regional producers can now create a wide range of products thanks to ongoing innovation in the market for drug delivery systems. During the anticipated period, collaborations between top industry players for improved technical developments in drug delivery solutions are also anticipated to drive the global market for drug delivery systems.
Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4768?AS
Service Providers
- Boston Scientific Corporation
- Johnson and Johnson Services, Inc.
- Pfizer, Inc.
- Baxter International, Inc.
- Amgen, Inc.
- Novartis AG
- F. Hoffmann La-Roche Ltd
- Bayer AG.
Key Statistics Supporting the Surge
- By delivery type, targeted drug delivery shall grow at a CAGR of 6.8%, accounting for almost half of the global drug delivery systems market. However, polymeric drug delivery is expected to grow the fastest at the rate of 7.3% during the forecast period. Use of nanotechnology and localized drug delivery are key growth drivers for both segments.
- By application, the oncology segment shall expand the fastest at a CAGR of 7.5% while the CNS segment shall grow at a CAGR of 6.9%. Rising prevalence of cancer and neurological disorders have boosted the demand for enhanced drug delivery devices, thus boosting the overall market share.
- By route of administration, the injectables segment shall capture a major chunk of the global drug delivery systems market, constituting 44.6% market share. The oral segment is close behind, capturing nearly 2/5th of the global drug delivery systems market. Faster drug delivery at the affected site drives the growth of the injectables segment while advancements in oral drug formulations such as solid lipid nanoparticles shall drive the growth of the oral drugs segment.
- By region, North America shall dominate the global drug delivery systems market, capturing nearly 40% of the market. At the same time, Asia-Pacific shall expand the fastest, at a CAGR of 7.8% across the forecast period. Increasing prevalence of acute chronic infections, introduction of advanced drug delivery devices and systems and favorable reimbursement policies for key players shall drive growth in both regions.
“Introduction of nanotechnology, coupled with three-dimensional printing and strengthening of existing and new drugs are poised to act as important growth stimulators of the global drug delivery systems market. Key manufacturers are exploiting the available opportunities to consolidate their foothold within the market,” concludes a Fact.MR analyst.
Workflow Optimization
Delivery System
- Intra Uterine Implants
- Pro-drug Implants
- Polymeric Drug Delivery
- Targeted Drug Delivery
Route of Administration
- Oral
- Injectable
- Inhalation
- Transdermal
- Ocular
- Nasal
- Topical
Application
- Infectious Disease
- Oncology
- Ophthalmology
- Urology
- Diabetes
- CNS
- Others
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
- Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)
Report Benefits & Key Questions Answered
- Drug Delivery Systems Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
- Drug Delivery Systems Historical volume analysis: The report provides a comparison of Drug Delivery Systems’ historical sales and projected sales performance for 2021-2031.
- Drug Delivery Systems Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Drug Delivery Systems market. It carefully gauges the impact of changing healthcare needs of key demographics globally
- Drug Delivery Systems Consumption by demographics: The report investigates consumer behavior affecting Drug Delivery Systems demand outlook for the assessment period. Effect of their keenness for digital trends on Drug Delivery Systems market is carefully analyzed
- Post COVID consumer spending on Drug Delivery Systems: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Drug Delivery Systems market growth.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4768?AS
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com